Cutler Group LLC / CA - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 128 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$107,000
+25.9%
4,320
+13.7%
0.01%
+20.0%
Q2 2020$85,000
+8400.0%
3,800
+280.0%
0.01%
Q3 2019$1,000
-99.3%
1,000
-71.4%
0.00%
-100.0%
Q1 2019$150,000
+2042.9%
3,500
+3400.0%
0.02%
+1500.0%
Q4 2018$7,000
-82.5%
100
-98.4%
0.00%
-66.7%
Q3 2018$40,000
-54.0%
6,100
+281.2%
0.00%
-57.1%
Q2 2018$87,000
+85.1%
1,600
-8.6%
0.01%
+75.0%
Q1 2018$47,000
+1466.7%
1,750
+457.3%
0.00%
Q3 2017$3,000
-92.7%
314
-96.9%
0.00%
-100.0%
Q2 2017$41,00010,200
+1033.3%
0.00%
Q1 2017$0
-100.0%
900
+50.0%
0.00%
Q4 2016$2,000
-33.3%
600
-90.2%
0.00%
Q3 2016$3,000
-97.7%
6,100
-44.0%
0.00%
-100.0%
Q2 2016$129,000
+279.4%
10,900
+222.5%
0.01%
+250.0%
Q1 2016$34,000
-72.4%
3,380
-55.4%
0.00%
-71.4%
Q4 2015$123,0007,5800.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders